HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression
about
Patterns of Chromosomal Aberrations in Solid TumorsBeyond RAS and BRAF: a target rich disease that is ripe for pickingSignificance of human epidermal growth factor receptor 2 expression in colorectal cancer.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis.Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian Country.Human Epidermal Growth Factor Receptor Expression in Colorectal Cancer and Its Relationship with Clinicopathological Characteristics.HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer.Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 AmplificationGenetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid CarcinomaHER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives.Molecular Testing for Gastrointestinal Cancer.Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2HER2 expression status in diverse cancers: review of results from 37,992 patients.Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression.Challenging chemoresistant metastatic colorectal cancer: therapeutic strategies from the clinic and from the laboratory.Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal Cancer.Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients.Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.Targeted next generation sequencing in Chinese colorectal cancer patients guided anti-EGFR treatment and facilitated precision cancer medicine.miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.Upper gastrointestinal malignancies in 2017: current perspectives and future approaches.HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.Colorectal cancer genomics and designing rational trials.Eastern Canadian Colorectal Cancer Consensus Conference 2017Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
P2860
Q26786127-D4A0B821-F8B5-4D1B-9BC5-A75B14B13557Q28066095-14BA17E6-21A2-4DBF-A65E-FB154C123B68Q34585338-DC49C01C-0B67-475B-BE57-03A38514F5C1Q35815603-EEB0E9AD-FC03-4F91-954E-69C09D22511DQ35962621-8F6B0C16-9682-4ABA-A05B-E54191D3EF06Q36115580-7D25A0FF-E0FD-4DFB-AE18-A23B4641BD20Q36184699-0F6D28C0-E709-4C6A-AF42-9A63F403E1C3Q36636356-B4DE3A4F-1C95-4D85-A5F7-EB4ACC1AF6AFQ36772167-5BF4E183-5021-4653-B552-7A6BA74312BEQ36843773-E10BBD9C-43DF-4989-B979-53C2B56F7E12Q37045824-A07302D5-1A36-4E9A-9A38-43A8F9714A96Q37377544-57016A28-5955-44B1-BA64-9B9C94A8D973Q37708897-12330B7E-B18D-4474-9561-104D18229C5BQ37710556-BE3FAC2D-A74E-4B76-9331-7844415156EEQ37741398-A4CD9230-0AE9-40C7-A270-D9441FF7E62FQ38364900-7F2D76CE-9AED-4EE4-8C7F-D1B919853254Q38384113-C3238A3D-4097-4FD4-9E6D-FF8A985AFE6FQ38704805-0E11FAFC-0773-4F61-8E47-5447F0AB4CE3Q38827897-C2A28E46-7247-4BE4-8556-7CBC915C6BB9Q39045763-85EE67A7-AB20-4D74-8F4B-6873F74EF4EDQ40176588-8A9DF3C9-6D3A-4EB3-B1D8-06A26FC83185Q48234912-6BA3376E-6A1B-4F98-97AA-85F9A88D1C81Q49417294-8CC878F6-A845-4DAE-B1B0-86F26125D8D1Q50595113-FC9A4A50-F052-4868-9868-B2427C241355Q52654643-A6F7DCBC-DAA5-4162-B246-107609095D4FQ54286661-FD53CB73-0C0A-476D-B41E-E166D9EDB045Q54962247-B1358971-BF36-4200-9CB6-980F311A846EQ55113382-05FB6365-EFB5-43F4-AE00-39ABD60D9661Q55306266-CE55F7EB-515C-4CC8-812A-2299D2953064Q58783221-A0634051-766F-4E5A-86EC-F82C2344FC51Q58803127-0C5D08DE-3BEF-4807-9D14-FE37AF8569B0
P2860
HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HER2 status in colorectal canc ...... e amplification and expression
@ast
HER2 status in colorectal canc ...... e amplification and expression
@en
type
label
HER2 status in colorectal canc ...... e amplification and expression
@ast
HER2 status in colorectal canc ...... e amplification and expression
@en
prefLabel
HER2 status in colorectal canc ...... e amplification and expression
@ast
HER2 status in colorectal canc ...... e amplification and expression
@en
P2093
P2860
P1433
P1476
HER2 status in colorectal canc ...... e amplification and expression
@en
P2093
Duck-Woo Kim
Gheeyoung Choe
Sung-Bum Kang
Woo Ho Kim
Yoonjin Kwak
P2860
P304
P356
10.1371/JOURNAL.PONE.0098528
P407
P577
2014-05-30T00:00:00Z